Clinical Trials Directory

Trials / Unknown

UnknownNCT03864887

Optical Assessment on Brain Death Via a Oxygen Supply Procedure

Optical Assessment on Brain Death Via a Multiple-phase Protocol at Varied Fraction of Inspired O2

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Chinese Academy of Medical Sciences · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study aims to evaluate brain death with optical probes. The changes of hemodynamic parameters including oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) were detected by near infrared spectroscopy probes attached on the forehead of patients. A multiple-phase protocol at varied fraction of inspired O2 were utilized during the assessment.

Detailed description

Brain death is an irreversible loss of all brain functions, and the assessment is crucial for organ supply for transplantation. The noninvasive, sensitive, universally available and timely ancillary method to assess brain death has not been established. This study aims to evaluate brain death with optical probes. The changes of hemodynamic parameters including oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) were detected by near infrared spectroscopy probes attached on the forehead of patients. A multiple-phase protocol at varied fraction of inspired O2 were utilized during the assessment. The concentration changes ratios of oxyhemoglobin to deoxyhemoglobin (Δ\[HbO2\]/Δ\[Hb\]) in the cerebral cortex of brain-dead patients were significantly higher than those of healthy subjects.

Conditions

Interventions

TypeNameDescription
PROCEDUREOxygen supply of high-low-high procedureThe protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 60% FIO2 (phase I, high oxygen), half-hour measurement at 40% FIO2 (phase II, low oxygen) and half-hour measurement at 60% FIO2 (phase III, high oxygen).
PROCEDUREOxygen supply of low-high-low procedureThe protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 40% FIO2 (phase I, low oxygen), half-hour measurement at 60% FIO2 (phase II, high oxygen) and half-hour measurement at 40% FIO2 (phase III, low oxygen).
DEVICEOptical monitor for hemodynamic parameter.Near infrared spectroscopy probes of tow wavelengths were attached on the subjects' foreheat to detect the changes of hemodynamic parameters.

Timeline

Start date
2019-02-11
Primary completion
2019-08-01
Completion
2019-12-31
First posted
2019-03-06
Last updated
2019-03-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03864887. Inclusion in this directory is not an endorsement.